Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pyxis Oncology Inc (PYXS)

Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pyxis Oncology Inc 321 HARRISON AVENUE BOSTON MA 02118 USA

www.pyxisoncology.com Employees: 50 P: 617-221-9059

Description:

Pyxis Oncology Inc. is a preclinical oncology company. It focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers. The company's product pipeline includes antibody drug conjugate and monoclonal antibody. Pyxis Oncology Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 227,160
Enterprise Value, $K 216,020
Shares Outstanding, K 59,466
Annual Sales, $ 0 K
Annual Net Income, $ -73,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -17,300 K
EBIT, $ -68,760 K
EBITDA, $ -71,620 K
60-Month Beta 1.27
% of Insider Shareholders 9.80%
% of Institutional Shareholders 39.09%
Float, K 53,638
% Float 90.20%
Short Volume Ratio 0.54

Growth:

1-Year Return 47.61%
3-Year Return -70.25%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.35 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -1.24
EPS Growth vs. Prev Qtr -20.69%
EPS Growth vs. Prev Year 37.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PYXS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.23%
Return-on-Assets % -28.76%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 12.84
Price/Cash Flow N/A
Price/Book 1.61
Book Value/Share 2.88
Interest Coverage -1.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar